Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mode of Action of Ondansetron, a 5-HT Receptor 3 Antagonist, in Lactulose Induced Diarrhoea

NCT03833999 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT03833999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03833999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mode of Action of Ondansetron, a 5-HT Receptor 3 Antagonist, in Lactulose Induced Diarrhoea
Lead sponsor
University of Nottingham
Phase
Phase 4
Overall status
Completed
Start date
October 16, 2018
Completion date
June 27, 2019
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

motility disorder of intestine, ondansetron, small bowel water